Drugs Information Online
Drugs and diseases reference index

Drugs and diseases reference index

Drugs A-Z List

Diseases & Conditions A-Z List

Herbs & Supplements

Medical Dictionary

Full Article

Popular Drugs

Popular Diseases & Conditions

Drugs reference index «Norethindrone Acetate»

Norethindrone Acetate

Pronunciation: (nor-eth-IN-drone ASS-uh-TATE)Class: Progestin

Trade Names:Aygestin- Tablets 5 mg

Micronor (Canada)


Inhibits secretion of pituitary gonadotropins, thereby preventing follicular maturation and ovulation.



Norethindrone acetate is rapidly absorbed from GI tract. T max is approximately 2 h.


Rapid distribution of dorethindrone acetate.


Norethindrone is metabolized in the liver.


Norethindrone elimination is rapid, primarily in feces.

Indications and Usage

Treatment of secondary amenorrhea; endometriosis; abnormal uterine bleeding caused by hormonal imbalance in the absence of organic pathology (eg, uterine cancer).


Thrombophlebitis, thrombolic disorders, cerebral apoplexy, or a history of these conditions; markedly impaired liver function or liver disease; known or suspected carcinoma of the breast; undiagnosed vaginal bleeding; missed abortion; as a diagnostic test for pregnancy.

Dosage and Administration

Secondary Amenorrhea, Abnormal Uterine BleedingAdults

PO 2.5 to 10 mg/day for 5 to 10 days during second half of the theoretical menstrual cycle.


PO 5 mg/day initially for 2 wk, then increase in increments of 2.5 mg/day every 2 wk until 15 mg/day is achieved. Therapy may be continued at this level for 6 to 9 mo or until breakthrough bleeding demands temporary termination.

General Advice

  • Administer once daily, without regard to meals. Administer with food if GI upset occurs.


Store at controlled room temperature (59° to 86°F).

Drug Interactions


Elimination of norethindrone may be increased, decreasing the therapeutic effect.

Laboratory Test Interactions

Pregnanediol determinations may be altered; thyroid and LFT results may be affected; increased amounts of coagulation factors; reduced response to metyrapone test.

Adverse Reactions


Thrombophlebitis; cerebral thrombosis and embolism; hypertension; edema.


Depression; changes in libido; changes in appetite; headache; nervousness; dizziness; fatigue.


Allergic rash; melasma; chloasma; hirsutism; alopecia; erythema multiforme; erythema nodosum; hemorrhagic eruption; itching.


Neuro-ocular lesions (eg, retinal thrombosis, optic neuritis).


Breakthrough bleeding; spotting; amenorrhea; increased cervical erosion and secretion; cystitis.


Cholestatic jaundice.


Weight gain and loss.


Pulmonary embolism.


Premenstrual syndrome; backache.



Category X .


Excreted in breast milk.


Safety and efficacy not established.

Fluid retention

Use with careful observation when conditions that might be affected by fluid retention are present (eg, asthma, cardiac or renal dysfunction, epilepsy).

Mental depression

Carefully observe patients with history of depression.

Ophthalmic effects

Discontinue therapy if there are any sudden changes in vision or onset of proptosis, diplopia, migraine, papilledema, or retinal vascular lesions.

Patient Information

  • Instruct patient to take once daily as prescribed.
  • Advise patient that medication can be taken without regard to meals, but to take with food if GI upset occurs.
  • Warn women of childbearing potential of significant risks associated with taking this medication and becoming pregnant.
  • Instruct diabetic patient to monitor blood glucose more frequently when drug is started or dose is changed and to inform health care provider of significant changes in readings.
  • Instruct patient to report the following symptoms to health care provider: pain in groin or calves; sharp chest pain or sudden shortness of breath; abnormal vaginal bleeding; sudden severe headache or migraine headache; vision problems; yellowing of skin or eyes; or depression.

Copyright © 2009 Wolters Kluwer Health.

  • Aygestin MedFacts Consumer Leaflet (Wolters Kluwer)
  • Aygestin Prescribing Information (FDA)
  • Aygestin Concise Consumer Information (Cerner Multum)
  • Aygestin Detailed Consumer Information (PDR)
  • Aygestin Oral, Implantation, Parenteral Advanced Consumer (Micromedex) - Includes Dosage Information
  • Camila Prescribing Information (FDA)
  • Nor-QD MedFacts Consumer Leaflet (Wolters Kluwer)
  • Nor-QD Prescribing Information (FDA)
  • Nora-BE Prescribing Information (FDA)
  • Ortho Micronor Prescribing Information (FDA)

Comment «Norethindrone Acetate»